Skip to main content
Benaroya Research Institute

Main navigation

  • About BRI
    • Leadership
    • Faculty
    • Administrative Leaders
    • Together We Discover
    • Contact Us
  • Our Research
    • Centers of Discovery
      • Fundamental Immunology
      • Translational Immunology
      • Interventional Immunology
      • Systems Immunology
        • Bioinformatics at BRI
    • Labs
    • Biorepositories
      • Be a Part of BRI Research
    • Clinical Research
      • Allergies & Asthma Clinical Research
    • Core Labs
      • Cell And Tissue Analysis Group
      • Genomics Core
      • Human Immunophenotyping Core
      • Protein and Tetramer Core
        • Protein & Tetramer Core Ordering
    • Immune Tolerance Network
    • Scientific Publications
    • Scientific Meetings at BRI
      • Asthma Research Symposium
      • BRI Immunology Symposium: New Horizons in Immunity and Disease
      • Cross Autoimmunity Prevention Symposium
  • Collaborations with BRI
    • Opportunities for Collaboration
    • Technology Available for Licensing
  • News
    • Press Releases
  • Support our Research
    • Donate Now
    • BRI Events
      • BRI Open House
      • Immunology to Change Lives

Utility Menu

  • Immunology Learning Center
  • Autoimmune Life Blog
  • Careers
  • Clinical Research at VMMC
  • Donate
  • Search
    • Jun 2023

      Diminished responses to mRNA-based SARS-CoV-2 vaccines in individuals with rheumatoid arthritis on immune modifying therapies.

      JCI Insight
      Klebanoff SD, Rodda LB, Morishima C, Wener MH, Yuzefpolskiy Y, Bettelli E, Buckner JH, Speake C, Pepper M, Campbell DJ
    • May 2022

      STAT1 signaling protects self-reactive T cells from control by innate cells during neuroinflammation.

      JCI Insight
      Arbelaez CA, Palle P, Charaix J, Bettelli E
    • Mar 2022

      Cutting Edge: Effect of Disease-Modifying Therapies on SARS-CoV-2 Vaccine-Induced Immune Responses in Multiple Sclerosis Patients.

      J Immunol
      Yuzefpolskiy Y, Morawski P, Fahning M, Speake C, Lord S, Chaudhary A, Morishima C, Wener MH, Kita M, McCarthy L, Buckner JH, Campbell DJ, Bettelli E
    • Nov 2021

      Cutting Edge: DOCK8 Regulates a Subset of Dendritic Cells That Is Critical for the Development of Experimental Autoimmune Encephalomyelitis.

      J Immunol
      Weliwitigoda A, Palle P, Gessner M, Hubbard NW, Oukka M, Bettelli E
    • Oct 2020

      Circulating TFH cells as a marker for early therapeutic intervention in T1D.

      Nat Immunol
      Bettelli E, Campbell DJ
    • Mar 2019

      Abatacept Targets T Follicular Helper and Regulatory T Cells, Disrupting Molecular Pathways That Regulate Their Proliferation and Maintenance.

      J Immunol
      Glatigny S, Höllbacher B, Motley SJ, Tan C, Hundhausen C, Buckner JH, Smilek D, Khoury SJ, Ding L, Qin T, Pardo J, Nepom GT, Turka LA, Harris KM, Campbell DJ, Bettelli E
    • Dec 2018

      Regulation of lymphocyte trafficking in central nervous system autoimmunity.

      Curr Opin Immunol
      Oukka M, Bettelli E
    • Nov 2018

      Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS).

      Cold Spring Harb Perspect Med
      Glatigny S, Bettelli E
    • Oct 2017

      S1P1 deletion differentially affects TH17 and Regulatory T cells.

      Sci Rep
      Eken A, Duhen R, Singh AK, Fry M, Buckner JH, Kita M, Bettelli E, Oukka M
    • Oct 2017

      DOCK8 regulates fitness and function of regulatory T cells through modulation of IL-2 signaling.

      JCI Insight
      Singh AK, Eken A, Hagin D, Komal K, Bhise G, Shaji A, Arkatkar T, Jackson SW, Bettelli E, Torgerson TR, Oukka M
    • May 2016

      Cutting Edge: Integrin α4 Is Required for Regulatory B Cell Control of Experimental Autoimmune Encephalomyelitis.

      J Immunol
      Glatigny S, Wagner CA, Bettelli E
    • Aug 2014

      DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs.

      Nat Commun
      Singh AK, Eken A, Fry M, Bettelli E, Oukka M
    • May 2013

      Cutting edge: the pathogenicity of IFN-γ-producing Th17 cells is independent of T-bet.

      J Immunol
      Duhen R, Glatigny S, Arbelaez CA, Blair TC, Oukka M, Bettelli E
    • Dec 2011

      Cutting edge: loss of α4 integrin expression differentially affects the homing of Th1 and Th17 cells.

      J Immunol
      Glatigny S, Duhen R, Oukka M, Bettelli E
Benaroya Research Institute

1201 Ninth Avenue
Seattle, WA 98101-2795
(206) 342-6500

facebook Bluesky instagram linkedin youtube threads
Resources
  • Support our Research
  • Subscribe to News
  • Careers
  • Contact Us
  • Research Conflicts of Interest
  • Research Security Program
  • Terms of Use
  • Research Requirements
If you would like to contact us regarding the accessibility of our website, please contact us at 206-342-6500 or email communications@benaroyaresearch.org.
© 2025 Benaroya Research Institute, a 501(c)(3) nonprofit organization
Close Close